Snowball logo
logo
AMPH

Amphastar Pharmaceuticals, Inc

$29.37+$0.50Β  (1.73%)
πŸ’‘ Click on a row in the table to make it appear on the graph
πŸ“Š Compare financials of multiple companies on the same chart
This feature is available with our premium plans. Upgrade to unlock the full potential of Snowball Analytics and be on top of your investments!
20212022202320242025TTM
Revenue
Total revenue
437.8499644.4732719.9745.8
COGS
238250.1293.3358.1363.8396.7
Gross Profit
199.7248.9351.1373.9356.1349.1
Operating Expenses & Income
Operating Income
69.89107.5197205.4140.4139.7
Total Operating Expenses
129.9141.4154.1168.4215.7209.4
R&D Expenses
60.9374.7773.7473.9185.8492.29
Selling General & Admin Expenses
51.4345.0651.5456.7285.9269.58
Earnings from Continuing Operations
Interest Expense
(0.885)(1.846)(27.16)(30.34)(25.48)(26.6)
Interest Income
0.6011.3213.73610.618.6797.11
Income Tax Expense
20.6323.4831.8329.6725.5330.61
Net Income
Net Income
62.1291.39137.5159.598.0998.96
Supplemental
EBIT
85.02117.9198.5220.1149.1156.2
EBITDA
110.5146.2240.3277.3212.3220.7
In millions of USD, except % and values per 1 share